COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological study.
Sancilio A, Schrock JM, Demonbreun AR, D'Aquila RT, Mustanski B, Vaught LA, Reiser NL, Velez MP, Hsieh RR, Ryan DT, Saber R, McNally EM, McDade TW.
Sancilio A, et al. Among authors: mustanski b.
Sci Rep. 2022 Jul 18;12(1):12269. doi: 10.1038/s41598-022-15791-6.
Sci Rep. 2022.
PMID: 35851303
Free PMC article.